Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1

Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2024-09, Vol.67 (18), p.15931-15946
Hauptverfasser: Hendrickson-Rebizant, Thordur, Sudhakar, Sadhana R. N., Rowley, Michael J., Frankel, Adam, Davie, James R., Lakowski, Ted M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15946
container_issue 18
container_start_page 15931
container_title Journal of medicinal chemistry
container_volume 67
creator Hendrickson-Rebizant, Thordur
Sudhakar, Sadhana R. N.
Rowley, Michael J.
Frankel, Adam
Davie, James R.
Lakowski, Ted M.
description Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.
doi_str_mv 10.1021/acs.jmedchem.4c00490
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11440505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3102470738</sourcerecordid><originalsourceid>FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</originalsourceid><addsrcrecordid>eNp9kU9PGzEQxS3UClLab1BVPvbAhvG_bPZURai0SKAiwd3yemeJkddObS9Svj0bElB74TSW5r034_kR8pXBnAFn58bm-eOAnV3jMJcWQDZwRGZMcajkEuQHMgPgvOILLk7Ip5wfAUAwLo7JiWi4AinkjKS7kkZbxoRn9HIMtrgYzqgJHV1N7ydXtjT29G4w3tOb6NGOHl_at7gprkN6FdaudSWmvBPepljQBbpKDy64gPQGy3rrSzIh95hMRso-k4-98Rm_HOopub_8eX_xu7r-8-vqYnVdGcGbUjULW9uOLxpQtUDG6q5WphWs65G3XC5NrzpsGZdC9Uts1UJ1tsPdF5u2b3pxSn7sYzdjuzsThmkLrzfJDSZtdTRO_98Jbq0f4pNmTEpQoKaE74eEFP-OmIseXLbovQkYx6zFxEHWUIvlJJV7qU0x54T92xwGeodLT7j0Ky59wDXZvv2745vplc8kgL3gxR7HFKaLvZ_5DKBDpzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102470738</pqid></control><display><type>article</type><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><source>ACS Publications</source><creator>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</creator><creatorcontrib>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</creatorcontrib><description>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</description><identifier>ISSN: 0022-2623</identifier><identifier>ISSN: 1520-4804</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.4c00490</identifier><identifier>PMID: 39250434</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2024-09, Vol.67 (18), p.15931-15946</ispartof><rights>2024 The Authors. Published by American Chemical Society</rights><rights>2024 The Authors. Published by American Chemical Society 2024 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</cites><orcidid>0009-0000-8709-5599 ; 0009-0005-8030-3961 ; 0000-0002-0420-6888 ; 0009-0000-8965-7786 ; 0000-0002-6625-6717</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00490$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.4c00490$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,315,781,785,886,2766,27081,27929,27930,56743,56793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39250434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hendrickson-Rebizant, Thordur</creatorcontrib><creatorcontrib>Sudhakar, Sadhana R. N.</creatorcontrib><creatorcontrib>Rowley, Michael J.</creatorcontrib><creatorcontrib>Frankel, Adam</creatorcontrib><creatorcontrib>Davie, James R.</creatorcontrib><creatorcontrib>Lakowski, Ted M.</creatorcontrib><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</description><issn>0022-2623</issn><issn>1520-4804</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU9PGzEQxS3UClLab1BVPvbAhvG_bPZURai0SKAiwd3yemeJkddObS9Svj0bElB74TSW5r034_kR8pXBnAFn58bm-eOAnV3jMJcWQDZwRGZMcajkEuQHMgPgvOILLk7Ip5wfAUAwLo7JiWi4AinkjKS7kkZbxoRn9HIMtrgYzqgJHV1N7ydXtjT29G4w3tOb6NGOHl_at7gprkN6FdaudSWmvBPepljQBbpKDy64gPQGy3rrSzIh95hMRso-k4-98Rm_HOopub_8eX_xu7r-8-vqYnVdGcGbUjULW9uOLxpQtUDG6q5WphWs65G3XC5NrzpsGZdC9Uts1UJ1tsPdF5u2b3pxSn7sYzdjuzsThmkLrzfJDSZtdTRO_98Jbq0f4pNmTEpQoKaE74eEFP-OmIseXLbovQkYx6zFxEHWUIvlJJV7qU0x54T92xwGeodLT7j0Ky59wDXZvv2745vplc8kgL3gxR7HFKaLvZ_5DKBDpzg</recordid><startdate>20240926</startdate><enddate>20240926</enddate><creator>Hendrickson-Rebizant, Thordur</creator><creator>Sudhakar, Sadhana R. N.</creator><creator>Rowley, Michael J.</creator><creator>Frankel, Adam</creator><creator>Davie, James R.</creator><creator>Lakowski, Ted M.</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0000-8709-5599</orcidid><orcidid>https://orcid.org/0009-0005-8030-3961</orcidid><orcidid>https://orcid.org/0000-0002-0420-6888</orcidid><orcidid>https://orcid.org/0009-0000-8965-7786</orcidid><orcidid>https://orcid.org/0000-0002-6625-6717</orcidid></search><sort><creationdate>20240926</creationdate><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><author>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hendrickson-Rebizant, Thordur</creatorcontrib><creatorcontrib>Sudhakar, Sadhana R. N.</creatorcontrib><creatorcontrib>Rowley, Michael J.</creatorcontrib><creatorcontrib>Frankel, Adam</creatorcontrib><creatorcontrib>Davie, James R.</creatorcontrib><creatorcontrib>Lakowski, Ted M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hendrickson-Rebizant, Thordur</au><au>Sudhakar, Sadhana R. N.</au><au>Rowley, Michael J.</au><au>Frankel, Adam</au><au>Davie, James R.</au><au>Lakowski, Ted M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2024-09-26</date><risdate>2024</risdate><volume>67</volume><issue>18</issue><spage>15931</spage><epage>15946</epage><pages>15931-15946</pages><issn>0022-2623</issn><issn>1520-4804</issn><eissn>1520-4804</eissn><abstract>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39250434</pmid><doi>10.1021/acs.jmedchem.4c00490</doi><tpages>16</tpages><orcidid>https://orcid.org/0009-0000-8709-5599</orcidid><orcidid>https://orcid.org/0009-0005-8030-3961</orcidid><orcidid>https://orcid.org/0000-0002-0420-6888</orcidid><orcidid>https://orcid.org/0009-0000-8965-7786</orcidid><orcidid>https://orcid.org/0000-0002-6625-6717</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2024-09, Vol.67 (18), p.15931-15946
issn 0022-2623
1520-4804
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11440505
source ACS Publications
title Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T02%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure,%20Function,%20and%20Activity%20of%20Small%20Molecule%20and%20Peptide%20Inhibitors%20of%20Protein%20Arginine%20Methyltransferase%201&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Hendrickson-Rebizant,%20Thordur&rft.date=2024-09-26&rft.volume=67&rft.issue=18&rft.spage=15931&rft.epage=15946&rft.pages=15931-15946&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.4c00490&rft_dat=%3Cproquest_pubme%3E3102470738%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3102470738&rft_id=info:pmid/39250434&rfr_iscdi=true